Current Standard of Care in Metastatic/Advanced Bladder Urothelial Carcinoma

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Faculty

Thomas B. Powles, MBBS, MRCP, MD

Barts Cancer
Center Barts & The London School of Medicine & Dentistry
Queen Mary University of London
London, United Kingdom

Disclosures

Grants for clinical research from: Astellas; AstraZeneca; Bristol Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer, Inc.; Roche; Seagen Inc., formerly Seattle Genetics, Inc.
Advisor or consultant for: Astellas; AstraZeneca; Bristol Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; Merck; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer, Inc.; Roche; Seagen Inc., formerly Seattle Genetics Inc.
Other: Travel/Accommodation/Expenses from: AstraZeneca; Ipsen; Merck Sharp & Dohme; Pfizer, Inc.; Roche

Enrique Grande, MD, PhD

Department of Medical Oncology
MD Anderson Cancer Center
Madrid, Spain

Disclosures

Grants for clinical research from: Ipsen; Merck KGaA; MTEM; Nanostring Technologies; Pfizer, Inc.; Roche; Tersera; Threshold
Advisor or consultant for: AstraZeneca; Bristol Myers Squibb; Eisai; Ipsen; Lilly; Merck KGaA; Merck Sharp & Dohme; Pfizer, Inc.; Roche
Speaker or member of speakers bureau for: Advanced Accelerator Applications; Astellas; AstraZeneca; Bristol Myers Squibb; Dr. Reddy’s; Eisai; Ipsen; Janssen; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer, Inc.; Roche; Sanofi-Genzyme; Tecnofarma; Zodiac

Editor

Walid Amara, MD

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Walid Amara, MD, has disclosed the following relevant financial relationships: Consultant or advisor for: Biotronik; Speaker or member of speakers bureau for: Boston Scientific; Medtronic; Microport Crm.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has disclosed no relevant financial relationships.